Le Lézard
Classified in: Health
Subjects: RCL, PSF

Updated Food Recall Warning (Allergen) - Schneiders brand Country Naturals Wieners recalled due to undeclared milk


Product photos are available at: https://bit.ly/2zBWLGV

OTTAWA, Nov. 8, 2018 /CNW/ - The food recall warning issued on October 17, 2018 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Maple Leaf Foods Inc. is recalling Schneiders brand Country Naturals Wieners from the marketplace because they may contain milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below. 

The following product has been sold nationally.

Recalled product

 

Brand

Product

Size

UPC

Codes

Schneiders

Country Naturals Wieners

375 g

0 62000 10879 7

Best Before 2018 OC 22 8219

Best Before 2019 JA 02

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to milk, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of these product codes. There was one reported reaction associated with the product code described in the Food Recall Warning of October 17, 2018.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...

at 07:02
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA's...

at 07:01
101 Mobility, a leading provider of mobility and accessibility solutions, is thrilled to announce the return of Chris Diehl to its Home Office Team. Chris rejoins 101 Mobility in the role of Director of National Accounts, where he will focus on...



News published on and distributed by: